InvestorsHub Logo
icon url

HyGro

12/12/21 11:37 AM

#196550 RE: Richard_Cranium #196547

But yet, LL has failed the CD12 Severe/Critical trial meeting none of the primary or secondary endpoints. The LL Long CoV trial also failed to meet its endpoints also. Until they actually meet clinical trial endpoints they will not be approved for broad scale medical use.
icon url

PNW_Ironman

12/12/21 12:00 PM

#196552 RE: Richard_Cranium #196547

It may be way past time to boil the tar and get some feathers, we just don’t know yet.